2009 annual financial data
Tenax Therapeutics 2009 Net margin
Direct answer
Net margin was -22,174.01%.
Operating income was -10,201,496 USD and net income was -10,507,376 USD.
Operating cash flow was -4,057,633 USD.
Get free Tenax Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 47,386 USD
- Operating income
- -10,201,496 USD
- Net income
- -10,507,376 USD
- Operating cash flow
- -4,057,633 USD